Novel anti-PD-L1/IL-15 bifunctional immunotherapeutics potentiates antitumor immunity

被引：0
|
作者：
Wu, Yan
Zhong, Zhaojing
Martomo, Stella
Lu, Dan
Zhang, Haifan
Polonskaya, Zhanna
Luna, Xenia
Zhang, Zhikai
Wang, Zhun
Liu, Leo
Patel, Jeegar
Tonra, James
Li, Henry
Witte, Larry
Waksal, Sam
Zhu, Zhenping
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4997
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4997
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Hyperprogressive disease with anti-PD-1 and anti-PD-L1
    Brower, Vicki
    LANCET ONCOLOGY, 2016, 17 (12): : E527 - E527
  • [32] Follicular helper-T cells restore CD8+-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy
    Niogret, Julie
    Berger, Helene
    Rebe, Cedric
    Mary, Romain
    Ballot, Elise
    Truntzer, Caroline
    Thibaudin, Marion
    Derangere, Valentin
    Hibos, Christophe
    Hampe, Lea
    Rageot, David
    Accogli, Theo
    Joubert, Philippe
    Routy, Bertrand
    Harker, James
    Vegran, Frederique
    Ghiringhelli, Francois
    Chalmin, Fanny
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)
  • [33] Regulation of natural killer cell development and antitumor immunity by the IL-15 system
    Lee, Gilbert A.
    Liou, Yae-Huei
    Wang, Szu-Wen
    Jiang, Si-Tse
    Liao, Nan-Shih
    CANCER RESEARCH, 2012, 72
  • [34] Synergistic efficacy of anti-PD-L1/IL-15 fusion protein in combination with anti-CTLA-4 antibody in a murine orthotopic 4T1 breast carcinoma model
    Martomo, Stella
    Lu, Dan
    Patel, Jeegar
    Polonskaya, Zhanna
    Luna, Xenia
    McCracken, Kevin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [35] Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody
    Fallon, Jonathan K.
    Vandeveer, Amanda J.
    Schlom, Jeffrey
    Greiner, John W.
    ONCOTARGET, 2017, 8 (13) : 20558 - 20571
  • [36] IMMUNOTHERAPY Benefit with anti-PD-L1
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (02) : 70 - 70
  • [37] STING pathway activation by ATR inhibition potentiates the antitumor immune response to anti-PD-L1 antibody in small cell lung cancer
    Sen, Triparna
    CANCER RESEARCH, 2023, 83 (07)
  • [38] IGM-7354, an immunocytokine with IL-15 fused to an anti-PD-L1 IgM, induces NK and CD8+T cell mediated cytotoxicity of PD-L1-positive tumor cells
    Giffon, Thierry D.
    Desbois, Melanie
    Yakkundi, Poonam
    Calhoun, Susan
    Sekar, Keerthana
    Denson, Carolyn
    Kothambawala, Tasnim
    Pearson, Alexander
    Pandey, Sivani
    Pandya, Deepal
    Rosete, Rodnie
    Machado, Daniel
    Raichlen, Pat
    Ng, Dean
    Jain, Abhinav R.
    Funke, Roel
    Humke, Eric
    Hinton, Paul R.
    Wang, Beatrice
    Keyt, Bruce A.
    Kotturi, Maya F.
    Sinclair, Angus M.
    CANCER RESEARCH, 2023, 83 (07)
  • [39] Dendritic cell-intrinsic PTPN22 negatively regulates antitumor immunity and impacts anti-PD-L1 efficacy
    Acero-Bedoya, Santiago
    Higgs, Emily F.
    Martinez, Anna C.
    Tonea, Ruxandra
    Gajewski, Thomas F.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (10)
  • [40] Functions of IL-15 in anti-viral immunity: Multiplicity and variety
    Verbist, Katherine C.
    Klonowski, Kimberly D.
    CYTOKINE, 2012, 59 (03) : 467 - 478
12345